Home > Healthcare > Biotechnology > Biotechnology R&D > Gene Editing Market

Gene Editing Market Share

Report ID: GMI810
Published Date: May 2022
Report Format: PDF

Download Free Sample

Gene Editing Market Share

Some of the leading market players operating in the gene editing industry include

Horizon Discovery Ltd.
Sangamo Therapeutics, Inc.
GenScript
Integrated DNA Technologies, Inc.
Precision Biosciences
Bearn Therapeutics
Thermo Fisher Scientific Inc.
Intellia Therapeutics, Inc.
CRISPR Therapeutics
Caribou Biosciences, Inc

These industry participants are implementing various growth strategies with increased innovations and technology improvements to sustain market competition in gene editing market. These market players are undertaking several organic and inorganic growth strategies to garner higher market revenue in gene editing market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The gene editing industry is slated to surpass USD 19.9 billion by 2030 and is poised to record a 15.5% CAGR from 2022 to 2030 on account of the rise in technological advancements and the rapidly evolving CRISPR technology.

The CRISPR/Cas9 technology segment in the gene editing market is poised to record a 15.6% CAGR through 2030 owing to its benefits, including simplicity, easy use, and affordability.

The biotech and pharma companies end-user segment captured close to 45.5% of the gene editing market share in 2021 due to the rising focus on the development of new gene editing technologies.

The gene editing industry revenue from the cell line engineering application segment had crossed USD 2.2 billion in 2021 due to the swift developments and advancements in genome editing technologies.

North America held more than 38% of the gene editing industry share in 2021 and will record a significant CAGR through 2030 due to the higher burden of rare diseases in the U.S. and Canada.